News

27 June 2025. TTA will be on hiatus due to a ‘break’. Literal, and not a vacation! Articles and Alerts will resume at a date TBD in July. No, this shouldn’t happen to you–an unwanted hiatus for Editor ...
Transcarent closes Accolade buy, changes its game. Transcarent’s $621 million acquisition of Accolade was wrapped up in record time (two months from announcement). This takes the Nasdaq-listed ...
A company most have never heard of is snapping up provider networks, health plans, and management services. Astrana Health, a Southern California-based value-based care (VBC) company formerly known as ...
Medical device company Masimo may not be able to rid itself entirely of its meddlesome former CEO, Joe Kiani. In fact, if a court awards him the shares exercised under his various employment ...
Omada Health plans exit into the public markets. Omada, which has virtual health diabetes and hypertension management programs, reportedly filed an S-1 with the Securities and Exchange Commission (SEC ...
In news other than Walgreens and Optum/Change Healthcare–with more to come out of HIMSS in Orlando this week… The DOD/VA Cerner EHR went live on Saturday 9 March in the Capt. James A. Lovell Federal ...
VA moving forward with the 2026 Oracle Cerner rollout of (lucky?) 13 centers. In March, the Department of Veterans Affairs (VA) announced that the EHR Modernization (EHRM) for 2026 would be expanded ...
Not coming soon to a supermarket near you, but an interesting test at Sainsbury’s in Liverpool. The 2022 study by a team from Liverpool John Moores University (LJMU) was designed to move atrial ...
VillageMD to cut six locations in the Chicago area–five standalone, one attached to a Walgreens store. The clinics will close on 19 April. The irony is that VillageMD is headquartered in Chicago. In ...
The waning days of summer wrapped with a few moderate-sized fundings: India’s Qure.AI scored a $65 million Series D, bringing their total funding to $125 million. Leading the raise: Lightspeed and 360 ...
Teladoc formally responds to the Blue Orca Capital research report [].Their letter (PDF) via its legal counsel (King & Spalding) yesterday refutes Blue Orca’s allegations in a report on their stock ...